Absorbed dose microdistribution of 177Lu and 225Ac in a model of cancer associated fibroblasts

被引:0
|
作者
Tranel, J. [1 ]
Palm, S. [2 ]
Graves, S. A. [3 ]
Feng, F. Y. [1 ]
Hope, T. A. [1 ]
机构
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Univ Gothenburg, Gothenburg, Sweden
[3] Univ Iowa, Iowa City, IA USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-625
引用
收藏
页码:S209 / S209
页数:1
相关论文
共 50 条
  • [1] Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model
    Tranel, Jonathan
    Palm, Stig
    Graves, Stephen A.
    Feng, Felix Y.
    Hope, Thomas A.
    EJNMMI PHYSICS, 2022, 9 (01)
  • [2] Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model
    Jonathan Tranel
    Stig Palm
    Stephen A. Graves
    Felix Y. Feng
    Thomas A. Hope
    EJNMMI Physics, 9
  • [3] Dose-dependent relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radionuclide therapy
    Rumiantcev, M.
    Li, W.
    Lindner, S.
    Liubchenko, G.
    Resch, S.
    Bartenstein, P.
    Ziegler, S.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S363 - S363
  • [4] Comparison of S-Values and Absorbed Dose Rates at the Cellular Level in Prostate Cancer Cells Irradiated with 177Lu and 225Ac Labelled Compounds
    Miller, Cassandra
    Chausse, Guillaume
    Brosch-Lenz, Julia
    Benard, Francois
    Rahmim, Arman
    Uribe, Carlos
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [5] Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS
    Mikhail Rumiantcev
    Wei Bo Li
    Simon Lindner
    Grigory Liubchenko
    Sandra Resch
    Peter Bartenstein
    Sibylle I. Ziegler
    Guido Böning
    Astrid Delker
    EJNMMI Physics, 10
  • [6] Estimation of relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS
    Rumiantcev, Mikhail
    Li, Wei Bo
    Lindner, Simon
    Liubchenko, Grigory
    Resch, Sandra
    Bartenstein, Peter
    Ziegler, Sibylle I.
    Boening, Guido
    Delker, Astrid
    EJNMMI PHYSICS, 2023, 10 (01)
  • [7] Impact of cell geometry, cellular uptake region, and tumour morphology on 225Ac and 177Lu dose distributions in prostate cancer
    Miller, Cassandra
    Klyuzhin, Ivan
    Chausse, Guillaume
    Brosch-Lenz, Julia
    Koniar, Helena
    Shi, Kuangyu
    Rahmim, Arman
    Uribe, Carlos
    EJNMMI PHYSICS, 2024, 11 (01):
  • [8] Radiolabeling of a polypeptide polymer for intratumoral delivery of emitter, 225Ac, and emitter, 177Lu
    Shalgunov, Vladimir
    Engudar, Gokce
    Bohrmann, Lennart
    Wharton, Luke
    Maskell, Keiran
    Johann, Kerstin
    Barz, Matthias
    Schaffer, Paul
    Herth, Matthias M.
    Radchenko, Valery
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 104 : 11 - 21
  • [9] Comparison of therapeutic activity of [177Lu]Lu- and [225Ac]Ac-anti-CD20 ofatumumab in a disseminated lymphoma murine model
    Longtine, Mark
    Shim, Kyuhwan
    Abou, Diane
    Hoegger, Mark
    Thorek, Daniel
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [10] 177Lu/225Ac pretargeted dual-isotope therapy for treatment of GPA33(+) colorectal cancer
    Rinne, Sara S.
    Vaughn, Brett
    Guo, Hong-Fen
    Vargas, Daniela Burnes
    Salehi, Niloufar
    Xu, Hong
    Veach, Darren
    Vanpouille-Box, Claire
    Miller, Brian
    Larson, Steven
    Cheung, Nai-Kong
    Cheal, Sarah
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65